Search Reports
Categories
Categories

Global Aprepitant Capsules Market

Global Aprepitant Capsules Market Research Report 2025(Status and Outlook)

Report Code : PHA2785
Published Date : 17 July, 1905 | No of Pages: 130

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Aprepitant capsules are a pharmaceutical product classified as a neurokinin-1 (NK1) receptor antagonist, primarily used to prevent chemotherapy-induced nausea and vomiting (CINV) in cancer patients undergoing highly emetogenic chemotherapy (HEC) or moderately emetogenic chemotherapy (MEC). The drug works by blocking the binding of substance P to NK1 receptors in the brain, thereby reducing the activation of the vomiting reflex. Aprepitant is often administered as part of a combination therapy with other antiemetic agents, such as 5-HT3 receptor antagonists and corticosteroids, to enhance its efficacy. The capsules are typically available in dosage forms of 40 mg, 80 mg, and 125 mg, with branded versions like Emend dominating the market, though generic alternatives have gained traction in recent years. Its usage is well-established in oncology settings due to its proven effectiveness in managing acute and delayed phases of CINV, making it a critical component in supportive cancer care. Regulatory approvals from agencies such as the FDA and EMA have further solidified its position in the antiemetics market.

The global Aprepitant Capsules market size was estimated at USD 130.59 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Aprepitant Capsules market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Aprepitant Capsules market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Aprepitant Capsules market.
Global Aprepitant Capsules Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma

Market Segmentation (by Type)
80mg
125mg
Other

Market Segmentation (by Application)
Hospital
Pharmacy
Other

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Aprepitant Capsules Market
Overview of the regional outlook of the Aprepitant Capsules Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Aprepitant Capsules Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Aprepitant Capsules, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Aprepitant Capsules
      1.2 Key Market Segments
            1.2.1 Aprepitant Capsules Segment by Type
            1.2.2 Aprepitant Capsules Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Aprepitant Capsules Market Overview
      2.1 Global Market Overview
            2.1.1 Global Aprepitant Capsules Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Aprepitant Capsules Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Aprepitant Capsules Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Aprepitant Capsules Product Life Cycle
      3.3 Global Aprepitant Capsules Sales by Manufacturers (2020-2025)
      3.4 Global Aprepitant Capsules Revenue Market Share by Manufacturers (2020-2025)
      3.5 Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Aprepitant Capsules Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Aprepitant Capsules Market Competitive Situation and Trends
            3.8.1 Aprepitant Capsules Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Aprepitant Capsules Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Aprepitant Capsules Industry Chain Analysis
      4.1 Aprepitant Capsules Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Aprepitant Capsules Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Aprepitant Capsules Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Aprepitant Capsules Market
      5.7 ESG Ratings of Leading Companies
  6 Aprepitant Capsules Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Aprepitant Capsules Sales Market Share by Type (2020-2025)
      6.3 Global Aprepitant Capsules Market Size Market Share by Type (2020-2025)
      6.4 Global Aprepitant Capsules Price by Type (2020-2025)
  7 Aprepitant Capsules Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Aprepitant Capsules Market Sales by Application (2020-2025)
      7.3 Global Aprepitant Capsules Market Size (M USD) by Application (2020-2025)
      7.4 Global Aprepitant Capsules Sales Growth Rate by Application (2020-2025)
  8 Aprepitant Capsules Market Sales by Region
      8.1 Global Aprepitant Capsules Sales by Region
            8.1.1 Global Aprepitant Capsules Sales by Region
            8.1.2 Global Aprepitant Capsules Sales Market Share by Region
      8.2 Global Aprepitant Capsules Market Size by Region
            8.2.1 Global Aprepitant Capsules Market Size by Region
            8.2.2 Global Aprepitant Capsules Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Aprepitant Capsules Sales by Country
            8.3.2 North America Aprepitant Capsules Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Aprepitant Capsules Sales by Country
            8.4.2 Europe Aprepitant Capsules Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Aprepitant Capsules Sales by Region
            8.5.2 Asia Pacific Aprepitant Capsules Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Aprepitant Capsules Sales by Country
            8.6.2 South America Aprepitant Capsules Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Aprepitant Capsules Sales by Region
            8.7.2 Middle East and Africa Aprepitant Capsules Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Aprepitant Capsules Market Production by Region
      9.1 Global Production of Aprepitant Capsules by Region(2020-2025)
      9.2 Global Aprepitant Capsules Revenue Market Share by Region (2020-2025)
      9.3 Global Aprepitant Capsules Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Aprepitant Capsules Production
            9.4.1 North America Aprepitant Capsules Production Growth Rate (2020-2025)
            9.4.2 North America Aprepitant Capsules Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Aprepitant Capsules Production
            9.5.1 Europe Aprepitant Capsules Production Growth Rate (2020-2025)
            9.5.2 Europe Aprepitant Capsules Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Aprepitant Capsules Production (2020-2025)
            9.6.1 Japan Aprepitant Capsules Production Growth Rate (2020-2025)
            9.6.2 Japan Aprepitant Capsules Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Aprepitant Capsules Production (2020-2025)
            9.7.1 China Aprepitant Capsules Production Growth Rate (2020-2025)
            9.7.2 China Aprepitant Capsules Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Merck
            10.1.1 Merck Basic Information
            10.1.2 Merck Aprepitant Capsules Product Overview
            10.1.3 Merck Aprepitant Capsules Product Market Performance
            10.1.4 Merck Business Overview
            10.1.5 Merck SWOT Analysis
            10.1.6 Merck Recent Developments
      10.2 Sandoz
            10.2.1 Sandoz Basic Information
            10.2.2 Sandoz Aprepitant Capsules Product Overview
            10.2.3 Sandoz Aprepitant Capsules Product Market Performance
            10.2.4 Sandoz Business Overview
            10.2.5 Sandoz SWOT Analysis
            10.2.6 Sandoz Recent Developments
      10.3 Glenmark Pharmaceuticals
            10.3.1 Glenmark Pharmaceuticals Basic Information
            10.3.2 Glenmark Pharmaceuticals Aprepitant Capsules Product Overview
            10.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Product Market Performance
            10.3.4 Glenmark Pharmaceuticals Business Overview
            10.3.5 Glenmark Pharmaceuticals SWOT Analysis
            10.3.6 Glenmark Pharmaceuticals Recent Developments
      10.4 Chia Tai Tianqing Pharmaceutical Group
            10.4.1 Chia Tai Tianqing Pharmaceutical Group Basic Information
            10.4.2 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Overview
            10.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Market Performance
            10.4.4 Chia Tai Tianqing Pharmaceutical Group Business Overview
            10.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
      10.5 Qilu Pharmaceutical
            10.5.1 Qilu Pharmaceutical Basic Information
            10.5.2 Qilu Pharmaceutical Aprepitant Capsules Product Overview
            10.5.3 Qilu Pharmaceutical Aprepitant Capsules Product Market Performance
            10.5.4 Qilu Pharmaceutical Business Overview
            10.5.5 Qilu Pharmaceutical Recent Developments
      10.6 Camber Pharma
            10.6.1 Camber Pharma Basic Information
            10.6.2 Camber Pharma Aprepitant Capsules Product Overview
            10.6.3 Camber Pharma Aprepitant Capsules Product Market Performance
            10.6.4 Camber Pharma Business Overview
            10.6.5 Camber Pharma Recent Developments
  11 Aprepitant Capsules Market Forecast by Region
      11.1 Global Aprepitant Capsules Market Size Forecast
      11.2 Global Aprepitant Capsules Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Aprepitant Capsules Market Size Forecast by Country
            11.2.3 Asia Pacific Aprepitant Capsules Market Size Forecast by Region
            11.2.4 South America Aprepitant Capsules Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Aprepitant Capsules by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Aprepitant Capsules Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Aprepitant Capsules by Type (2026-2033)
            12.1.2 Global Aprepitant Capsules Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Aprepitant Capsules by Type (2026-2033)
      12.2 Global Aprepitant Capsules Market Forecast by Application (2026-2033)
            12.2.1 Global Aprepitant Capsules Sales (K MT) Forecast by Application
            12.2.2 Global Aprepitant Capsules Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400